TEST BANK
CALCULATIN
G DRUG
DOSAGES
2nd Edition
Castillo
,Werner-
McCullough
A Patient-
Safe
Approach to
Nursing and
Math
,Castillo/Werner-McCullough: |Calculating |Drug |Dosages: |A |Patient-Safe |Approach |to |Nursing |and |Math,,2e
Test |Bank
Table |of |Contents:
I. |Safety |in |Medication |Administration
Chapter |1. |Safety |in |Medication |Administration
Chapter |2. |The |Drug |Label
II. |Systems |of |Measurement
Chapter |3. |The |Metric |System
Chapter |4. |The |Household |System
III. |Methods |of |Calculation
Chapter |5. |Linear |Ratio |and |Proportion
Chapter |6. |Fractional |Ratio |and |Proportion
Chapter |7. |Dimensional |Analysis
Chapter |8. |Formula |Method
IV. |Administration |of |Medications
Chapter |9. |Calculating |Oral |Medication |Doses
Chapter |10. |Syringes |and |Needles
Chapter |11. |Calculating |Parenteral |Medication |Dosages
Chapter |12. |Preparing |Powdered |Parenteral |Medications
Chapter |13. |Administration |of |Insulin
V. |IV |Therapy |and |Administration |of |Intravenous |Medications
Chapter |14. |Intravenous |Infusion |and |Infusion |Rates
Chapter |15. |Calculating |Infusion |and |Completion |Time
Chapter |16. |Administering |IV |Push |Medications
VI. |Verifying |Safe |Dose |and |Critical |Care |Calculations
Chapter |17. |Verifying |Safe |Dose
Chapter |18. |Titration |of |Intravenous |Medications
VII. |Intake |and |Output
Chapter |19. |Calculating |Intake |and |Output
Chapter |20. |Calculating |Parenteral |Intake
VIII. |Dosages |for |Pediatric |and |Older |Adult |Populations
Chapter |21. |Considerations |for |the |Pediatric |Patient
Chapter |22. |Considerations |for |the |Older |Adult
, Chapter |1: |Safety |in |Medication |Administration
Castillo: |Calculating |Drug |Dosages: |A |Patient-Safe |Approach |to |Nursing |and |Math |2nd |Edition
MULTIPLE |CHOICE
1. The |following |medication |order |is |in |the |patient’s |medication |administration |record |(MAR):
methylPREDnisolone |40 |mg |PO |daily |at |0900.
After |reading |the |order, |the |nurse |correctly |determines:
A “PO” |is |an |inappropriate |abbreviation.
B the |medication |order |is |written |correctly.
C 40 |mg |should |be |written |as |40mg.
D tall |man |lettering |indicates |that |the |drug |is |a |narcotic.
ANS: |B
Feedback
The |medication |order |has |all |the |required |components |(drug |name, |dose, |route, |and
|frequency |of |administration) |for |a |drug |order. |“PO” |is |an |appropriate |abbreviation;
|40 |mg |is |written |correctly |with |a |space |between |the |dose |and |the |unit |of
|measurement. |Tall |man |lettering |is |used |to |distinguish |the |drug |from |another |drug
with |a |similar |name.
2. Which |of |the |following |accurately |describes |the |“Boxed |Warning” |found |on |a |drug |label?
A It |is |primarily |is |used |to |identify |the |safe |dose |for |the |patient.
B It |is |commonly |found |on |all |drug |labels.
C It |identifies |serious |potential |risks |and |side |effects |related |to |drug |use.
D It |protects |the |patient |by |providing |information |to |decrease |side |effects.
ANS: |C
Feedback
A |drug |label |with |a |boxed |warning |provides |information |to |healthcare |professionals
|and |patients |regarding |the |serious |risks |and |side |effects |related |to |the |drug. |The
|Boxed |Warning |is |not |the |primary |source |for |identifying |the |patient’s |drug |dosage.
The |warning |is |found |on |specific |prescription |medications |and |does |not |provide
|information |to |reduce |or |decrease |side |effects.
3. When |practicing |safety |in |the |administration |of |medication, |for |which |of |the |following
|medication |orders |should |a |nurse |seek |clarification |before |the |administration |of |the
|medication?
1
CALCULATIN
G DRUG
DOSAGES
2nd Edition
Castillo
,Werner-
McCullough
A Patient-
Safe
Approach to
Nursing and
Math
,Castillo/Werner-McCullough: |Calculating |Drug |Dosages: |A |Patient-Safe |Approach |to |Nursing |and |Math,,2e
Test |Bank
Table |of |Contents:
I. |Safety |in |Medication |Administration
Chapter |1. |Safety |in |Medication |Administration
Chapter |2. |The |Drug |Label
II. |Systems |of |Measurement
Chapter |3. |The |Metric |System
Chapter |4. |The |Household |System
III. |Methods |of |Calculation
Chapter |5. |Linear |Ratio |and |Proportion
Chapter |6. |Fractional |Ratio |and |Proportion
Chapter |7. |Dimensional |Analysis
Chapter |8. |Formula |Method
IV. |Administration |of |Medications
Chapter |9. |Calculating |Oral |Medication |Doses
Chapter |10. |Syringes |and |Needles
Chapter |11. |Calculating |Parenteral |Medication |Dosages
Chapter |12. |Preparing |Powdered |Parenteral |Medications
Chapter |13. |Administration |of |Insulin
V. |IV |Therapy |and |Administration |of |Intravenous |Medications
Chapter |14. |Intravenous |Infusion |and |Infusion |Rates
Chapter |15. |Calculating |Infusion |and |Completion |Time
Chapter |16. |Administering |IV |Push |Medications
VI. |Verifying |Safe |Dose |and |Critical |Care |Calculations
Chapter |17. |Verifying |Safe |Dose
Chapter |18. |Titration |of |Intravenous |Medications
VII. |Intake |and |Output
Chapter |19. |Calculating |Intake |and |Output
Chapter |20. |Calculating |Parenteral |Intake
VIII. |Dosages |for |Pediatric |and |Older |Adult |Populations
Chapter |21. |Considerations |for |the |Pediatric |Patient
Chapter |22. |Considerations |for |the |Older |Adult
, Chapter |1: |Safety |in |Medication |Administration
Castillo: |Calculating |Drug |Dosages: |A |Patient-Safe |Approach |to |Nursing |and |Math |2nd |Edition
MULTIPLE |CHOICE
1. The |following |medication |order |is |in |the |patient’s |medication |administration |record |(MAR):
methylPREDnisolone |40 |mg |PO |daily |at |0900.
After |reading |the |order, |the |nurse |correctly |determines:
A “PO” |is |an |inappropriate |abbreviation.
B the |medication |order |is |written |correctly.
C 40 |mg |should |be |written |as |40mg.
D tall |man |lettering |indicates |that |the |drug |is |a |narcotic.
ANS: |B
Feedback
The |medication |order |has |all |the |required |components |(drug |name, |dose, |route, |and
|frequency |of |administration) |for |a |drug |order. |“PO” |is |an |appropriate |abbreviation;
|40 |mg |is |written |correctly |with |a |space |between |the |dose |and |the |unit |of
|measurement. |Tall |man |lettering |is |used |to |distinguish |the |drug |from |another |drug
with |a |similar |name.
2. Which |of |the |following |accurately |describes |the |“Boxed |Warning” |found |on |a |drug |label?
A It |is |primarily |is |used |to |identify |the |safe |dose |for |the |patient.
B It |is |commonly |found |on |all |drug |labels.
C It |identifies |serious |potential |risks |and |side |effects |related |to |drug |use.
D It |protects |the |patient |by |providing |information |to |decrease |side |effects.
ANS: |C
Feedback
A |drug |label |with |a |boxed |warning |provides |information |to |healthcare |professionals
|and |patients |regarding |the |serious |risks |and |side |effects |related |to |the |drug. |The
|Boxed |Warning |is |not |the |primary |source |for |identifying |the |patient’s |drug |dosage.
The |warning |is |found |on |specific |prescription |medications |and |does |not |provide
|information |to |reduce |or |decrease |side |effects.
3. When |practicing |safety |in |the |administration |of |medication, |for |which |of |the |following
|medication |orders |should |a |nurse |seek |clarification |before |the |administration |of |the
|medication?
1
